We are live on ! Find out more
PALI icon

Palisade Bio
PALI

6 hedge funds and large institutions have $68.5M invested in Palisade Bio in 2014 Q2 according to their latest regulatory filings, with 3 funds opening new positions, increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 1

79% more call options, than puts

Call options by funds: $1.32M | Put options by funds: $736K

50% more funds holding

Funds holding: 4 → 6 (+2)

39% more capital invested

Capital invested by funds: $49.5M → $68.5M (+$19.1M)

0% more ownership

Funds ownership: 0% → 0% (+0%)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
6
Holders Change
+2
Holders Change %
+50%
% of All Funds
0.17%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
–
Reduced
1
Closed
1
Calls
$1.32M
Puts
$736K
Net Calls
+$581K
Net Calls Change
+$347K

Top Buyers

Rank Fund Capital Flow
1
BFA
BlackRock Fund Advisors
California
+$4.7M
2
BIT
BlackRock Institutional Trust
California
+$4.7M
3
State Street
State Street
Massachusetts
+$4.7M

Top Sellers

Rank Fund Capital Flow
1
CS
Credit Suisse
Switzerland
-$4.7M
2
FAM
Fred Alger Management
New York
-$4.7M
3
SFM
Soros Fund Management
New York
-$803K
4
PAM
Panagora Asset Management
Massachusetts
-$500K
5
LP
LMR Partners
United Kingdom
-$296K
Name Holding Trade Value Shares
Change 		Change in
Stake
PI
1
Putnam Investments
Massachusetts
$14.9M – – –
Vanguard Group
2
Vanguard Group
Pennsylvania
$11.1M – – –
BFA
3
BlackRock Fund Advisors
California
$7.2M +$4.7M +1 New
FAM
4
Fred Alger Management
New York
$6.03M -$4.7M -1 -50%
BIT
5
BlackRock Institutional Trust
California
$3.09M +$4.7M +1 New
State Street
6
State Street
Massachusetts
$2.75M +$4.7M +1 New
CS
7
Credit Suisse
Switzerland
$1.85M -$4.7M -1 Closed
Geode Capital Management
8
Geode Capital Management
Massachusetts
$1.83M – – –
Bank of New York Mellon
9
Bank of New York Mellon
New York
$1.32M – – –
Millennium Management
10
Millennium Management
New York
$1.18M – – –
D.E. Shaw & Co
11
D.E. Shaw & Co
New York
$1.18M – – –
TCIM
12
TIAA CREF Investment Management
New York
$1.1M – – –
IGIM
13
I.G. Investment Management
Manitoba, Canada
$1.06M – – –
Northern Trust
14
Northern Trust
Illinois
$981K – – –
Goldman Sachs
15
Goldman Sachs
New York
$873K – – –
BIM
16
BlackRock Investment Management
Delaware
$834K – – –
Morgan Stanley
17
Morgan Stanley
New York
$771K – – –
AQR Capital Management
18
AQR Capital Management
Connecticut
$751K – – –
Fifth Third Bancorp
19
Fifth Third Bancorp
Ohio
$739K – – –
Susquehanna International Group
20
Susquehanna International Group
Pennsylvania
$727K – – –
Jane Street
21
Jane Street
New York
$701K – – –
California Public Employees Retirement System
22
California Public Employees Retirement System
California
$657K – – –
BCM
23
Bridgeway Capital Management
Texas
$554K – – –
California State Teachers Retirement System (CalSTRS)
24
California State Teachers Retirement System (CalSTRS)
California
$530K – – –
LPL Financial
25
LPL Financial
California
$517K – – –
1
2 3 4

PALI Hedge Fund Activity: Q2 2014 in Review

6 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in Palisade Bio (PALI) for Q2 2014, worth a combined $68.5M — up 39% from $49.5M a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new PALI positions and 1 closed out — a net gain of 2 holders — while 0 added to existing stakes and 1 trimmed.

The largest buyer was BlackRock Fund Advisors, opening a new position worth an estimated $4.7M. The largest seller was Credit Suisse, exiting entirely with an estimated $4.7M sold.

  • 6 institutional investors held Palisade Bio (PALI) as of Q2 2014, up from 4 in Q1 2014.
  • Funds reported $68.5M of Palisade Bio stock for Q2 2014, up 39% quarter-over-quarter.
  • 3 funds opened new Palisade Bio positions in Q2 2014 and 1 closed out, a net change of +2 holders.
  • The largest Palisade Bio buyer in Q2 2014 was BlackRock Fund Advisors, an estimated $4.7M added.
  • The largest Palisade Bio seller in Q2 2014 was Credit Suisse, an estimated $4.7M sold.

Based on aggregated 13F filings for Q2 2014.